BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10435047)

  • 1. Angiotensin converting enzyme and angiotensin II type 1-receptor gene polymorphisms and risk of ischaemic heart disease.
    Rice GI; Foy CA; Grant PJ
    Cardiovasc Res; 1999 Mar; 41(3):746-53. PubMed ID: 10435047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type 1 receptor A1166C gene polymorphism. Absence of an association with the risk of coronary artery disease and myocardial infarction and of a synergistic effect with angiotensin-converting enzyme gene polymorphism on the risk of these diseases.
    Gardemann A; Nguyen QD; Humme J; Stricker J; Katz N; Tillmanns H; Hehrlein FW; Rau M; Haberbosch W
    Eur Heart J; 1998 Nov; 19(11):1657-65. PubMed ID: 9857918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease.
    Nakauchi Y; Suehiro T; Yamamoto M; Yasuoka N; Arii K; Kumon Y; Hamashige N; Hashimoto K
    Atherosclerosis; 1996 Sep; 125(2):161-9. PubMed ID: 8842348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the postulated interaction between the angiotensin II sub-type 1 receptor gene A1166C polymorphism and the insertion/deletion polymorphism of the angiotensin converting enzyme gene on risk of myocardial infarction.
    Steeds RP; Wardle A; Smith PD; Martin D; Channer KS; Samani NJ
    Atherosclerosis; 2001 Jan; 154(1):123-8. PubMed ID: 11137090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene and angiotensin-II type 1 receptor gene polymorphisms in patients with coronary artery disease.
    Gruchala M; Ciećwierz D; Ochman K; Wasag B; Koprowski A; Wojtowicz A; Dubaniewicz W; Targoński R; Sobiczewski W; Grzybowski A; Romanowski P; Limon J; Rynkiewicz A
    Clin Chem Lab Med; 2003 Apr; 41(4):522-8. PubMed ID: 12747597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of angiotensin-converting enzyme and angiotensin II receptor type 1 genes in essential hypertension in a Polish population.
    Dzida G; Sobstyl J; Puzniak A; Golon P; Mosiewicz J; Hanzlik J
    Med Sci Monit; 2001; 7(6):1236-41. PubMed ID: 11687736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease.
    Alvarez R; Reguero JR; Batalla A; Iglesias-Cubero G; Cortina A; Alvarez V; Coto E
    Cardiovasc Res; 1998 Nov; 40(2):375-9. PubMed ID: 9893731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
    Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
    Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms.
    Fatini C; Abbate R; Pepe G; Battaglini B; Gensini F; Ruggiano G; Gensini GF; Guazzelli R
    Eur Heart J; 2000 Apr; 21(8):633-8. PubMed ID: 10731400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myocardial infarction in young adults: prognostic role of angiotensin-converting enzyme, angiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein IIIa genetic polymorphisms at medium-term follow-up.
    Brscic E; Bergerone S; Gagnor A; Colajanni E; Matullo G; Scaglione L; Cassader M; Gaschino G; Di Leo M; Brusca A; Pagano GF; Piazza A; Trevi GP
    Am Heart J; 2000 Jun; 139(6):979-84. PubMed ID: 10827377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease.
    Buraczyńska M; Pijanowski Z; Spasiewicz D; Nowicka T; Sodolski T; Widomska - Czekajska T; Ksiazek A
    Kardiol Pol; 2003 Jan; 58(1):1-9. PubMed ID: 14502296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction.
    Samani NJ; O'Toole L; Martin D; Rai H; Fletcher S; Lodwick D; Thompson JR; Morice AH; Channer K; Woods KL
    J Am Coll Cardiol; 1996 Aug; 28(2):338-44. PubMed ID: 8800107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction.
    Tiret L; Bonnardeaux A; Poirier O; Ricard S; Marques-Vidal P; Evans A; Arveiler D; Luc G; Kee F; Ducimetière P
    Lancet; 1994 Oct; 344(8927):910-3. PubMed ID: 7934345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study.
    Jeunemaitre X; Ledru F; Battaglia S; Guillanneuf MT; Courbon D; Dumont C; Darmon O; Guize L; Guermonprez JL; Diebold B; Ducimetière P
    Hum Genet; 1997 Jan; 99(1):66-73. PubMed ID: 9003497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease.
    Winkelmann BR; Nauck M; Klein B; Russ AP; Böhm BO; Siekmeier R; Ihnken K; Verho M; Gross W; März W
    Ann Intern Med; 1996 Jul; 125(1):19-25. PubMed ID: 8644984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between gene polymorphisms of renin-angiotensin system and metabolic risk factors in premature myocardial infarction.
    Petrovic D; Zorc M; Kanic V; Peterlin B
    Angiology; 2001 Apr; 52(4):247-52. PubMed ID: 11330506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk for ischaemic events is related to combined RAS polymorphism.
    van Geel PP; Pinto YM; Zwinderman AH; Henning RH; van Boven AJ; Jukema JW; Bruschke AV; Kastelein JJ; van Gilst WH
    Heart; 2001 Apr; 85(4):458-62. PubMed ID: 11250978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries.
    Hamon M; Amant C; Bauters C; Richard F; Helbecque N; McFadden E; Lablanche JM; Bertrand M; Amouyel P
    Heart; 1997 Jun; 77(6):502-5. PubMed ID: 9227291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype distribution of angiotensin-converting enzyme polymorphism in Australian healthy and coronary populations and relevance to myocardial infarction and coronary artery disease.
    Wang XL; McCredie RM; Wilcken DE
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):115-9. PubMed ID: 8548410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of renin-angiotensin system, angiotensin І converting enzyme (insertion/deletion), and angiotensin ІІ type 1 receptor (A1166C) polymorphisms on breast cancer survival in Iran.
    Namazi S; Daneshian A; Mohammadianpanah M; Jafari P; Ardeshir-Rouhani-Fard S; Nasirabadi S
    Gene; 2013 Dec; 532(1):125-31. PubMed ID: 24055489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.